SARS-CoV-2 infects blood monocytes to activate NLRP3 and AIM2 inflammasomes, pyroptosis and cytokine release

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30566-3 · Cited by 27,263 · see citing works

Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China

Wu, C., Chen, X., Cai, Y., Xia, J., Zhou, X., Xu, S., Huang, H., Zhang, L., Zhou, X., Du, C., et al. (2020) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2020.0994 · Cited by 8,249 · see citing works

The MR-Base platform supports systematic causal inference across the human phenome

Hemani, G., Zheng, J., Elsworth, B., Wade, K. H., Haberland, V., Baird, D., Laurin, C., Burgess, S., Bowden, J., Langdon, R., et al. (2018) · eLife · doi:10.7554/elife.34408 · Cited by 7,959 · see citing works

Characteristics of SARS-CoV-2 and COVID-19

Hu, B., Guo, H., Zhou, P., & Shi, Z.-L. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-020-00459-7 · Cited by 5,291 · see citing works

The trinity of COVID-19: immunity, inflammation and intervention

Tay, M. Z., Poh, C. M., Rénia, L., MacAry, P. A., & Ng, L. F. P. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0311-8 · Cited by 4,360 · see citing works

Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19

Blanco-Melo, D., Nilsson-Payant, B. E., Liu, W.-C., Uhl, S., Hoagland, D., Møller, R., Jordan, T. X., Oishi, K., Panis, M., Sachs, D., et al. (2020) · Cell · doi:10.1016/j.cell.2020.04.026 · Cited by 4,222 · see citing works

Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores

Liu, X., Zhang, Z., Ruan, J., Pan, Y., Magupalli, V. G., Wu, H., & Lieberman, J. (2016) · Nature · doi:10.1038/nature18629 · Cited by 3,202 · see citing works

Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients

Hadjadj, J., Yatim, N., Barnabei, L., Corneau, A., Boussier, J., Smith, N., Péré, H., Charbit, B., Bondet, V., Chenevier-Gobeaux, C., et al. (2020) · Science · doi:10.1126/science.abc6027 · Cited by 2,984 · see citing works

Antibody responses to SARS-CoV-2 in patients with COVID-19

Long, Q.-X., Liu, B.-Z., Deng, H.-J., Wu, G.-C., Deng, K., Chen, Y.-K., Liao, P., Qiu, J.-F., Lin, Y., Cai, X.-F., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0897-1 · Cited by 2,876 · see citing works

Unraveling the polygenic architecture of complex traits using blood eQTL metaanalysis

Võsa, U., Claringbould, A., Westra, H.-J., Bonder, M. J., Deelen, P., Zeng, B., Kirsten, H., Saha, A., Kreuzhuber, R., Kasela, S., et al. (2018) · doi:10.1101/447367 · Cited by 2,607 · see citing works

Large-scale cis- and trans-eQTL analyses identify thousands of genetic loci and polygenic scores that regulate blood gene expression

Võsa, U., Claringbould, A., Westra, H.-J., Bonder, M. J., Deelen, P., Zeng, B., Kirsten, H., Saha, A., Kreuzhuber, R., Yazar, S., et al. (2021) · Nature Genetics · doi:10.1038/s41588-021-00913-z · Cited by 2,607 · see citing works

An inflammatory cytokine signature predicts COVID-19 severity and survival

Del Valle, D. M., Kim-Schulze, S., Huang, H.-H., Beckmann, N. D., Nirenberg, S., Wang, B., Lavin, Y., Swartz, T. H., Madduri, D., Stock, A., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-1051-9 · Cited by 2,605 · see citing works

Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages

Merad, M., & Martin, J. C. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0331-4 · Cited by 2,472 · see citing works

Interleukin-1 in the pathogenesis and treatment of inflammatory diseases

Dinarello, C. A. (2011) · Blood · doi:10.1182/blood-2010-07-273417 · Cited by 2,248 · see citing works

K+ Efflux Is the Common Trigger of NLRP3 Inflammasome Activation by Bacterial Toxins and Particulate Matter

Muñoz-Planillo, R., Kuffa, P., Martínez-Colón, G. J., Smith, B. L., Rajendiran, T. M., & Núñez, G. (2013) · Immunity · doi:10.1016/j.immuni.2013.05.016 · Cited by 2,167 · see citing works

PhenoScanner V2: an expanded tool for searching human genotype–phenotype associations

Kamat, M., Blackshaw, J., Young, R., Surendran, P., Burgess, S., Danesh, J., Butterworth, A. S., & Staley, J. R. (2019) · Bioinformatics · doi:10.1093/bioinformatics/btz469 · Cited by 2,159 · see citing works

Longitudinal analyses reveal immunological misfiring in severe COVID-19

Lucas, C., Wong, P., Klein, J., Castro, T. B. R., Silva, J., Sundaram, M., Ellingson, M. K., Mao, T., Oh, J. E., Israelow, B., et al. (2020) · Nature · doi:10.1038/s41586-020-2588-y · Cited by 2,074 · see citing works

Sensitivity Analyses for Robust Causal Inference from Mendelian Randomization Analyses with Multiple Genetic Variants

Burgess, S., Bowden, J., Fall, T., Ingelsson, E., & Thompson, S. G. (2017) · Epidemiology · doi:10.1097/ede.0000000000000559 · Cited by 2,017 · see citing works

Genomewide Association Study of Severe Covid-19 with Respiratory Failure

The Severe Covid-19 GWAS Group (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2020283 · Cited by 1,986 · see citing works

Cytokine release syndrome in severe COVID-19

Moore, J. B., & June, C. H. (2020) · Science · doi:10.1126/science.abb8925 · Cited by 1,912 · see citing works

Guidelines for performing Mendelian randomization investigations

Burgess, S., Smith, G. D., Davies, N. M., Dudbridge, F., Gill, D., Glymour, M. M., Hartwig, F. P., Holmes, M. V., Minelli, C., Relton, C. L., et al. (2019) · Wellcome Open Research · doi:10.12688/wellcomeopenres.15555.1 · Cited by 1,852 · see citing works

CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells

Wang, K., Chen, W., Zhang, Z., Deng, Y., Lian, J., Du, P. F., Wei, D., Yang, Z., Sun, X., Gong, L., et al. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00426-x · Cited by 1,592 · see citing works

PhenoScanner: a database of human genotype-phenotype associations.

Staley, J. R., Blackshaw, J., Kamat, M. A., Ellis, S., Surendran, P., Sun, B. B., Paul, D. S., Freitag, D., Burgess, S., Danesh, J., et al. (2016) · Bioinformatics · doi:10.1093/bioinformatics/btw373 · Cited by 1,479 · see citing works

The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses

Rathinam, V. A. K., Jiang, Z., Waggoner, S. N., Sharma, S., Cole, L. E., Waggoner, L., Vanaja, S. K., Monks, B. G., Ganesan, S., Latz, E., et al. (2010) · Nature Immunology · doi:10.1038/ni.1864 · Cited by 1,331 · see citing works

Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia

Salama, C., Han, J., Yau, L., Reiss, W. G., Krämer, B., Neidhart, J. D., Criner, G. J., Kaplan‐Lewis, E., Baden, R. P., Pandit, L. M., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2030340 · Cited by 1,285 · see citing works

Guidelines for performing Mendelian randomization investigations

Burgess, S., Davey Smith, G., Davies, N. M., Dudbridge, F., Gill, D., Glymour, M. M., Hartwig, F. P., Holmes, M. V., Minelli, C., Relton, C. L., et al. (2020) · Wellcome Open Research · doi:10.12688/wellcomeopenres.15555.2 · Cited by 1,273 · see citing works

FDA-approved disulfiram inhibits pyroptosis by blocking gasdermin D pore formation

Hu, J. J., Liu, X., Xia, S., Zhang, Z., Zhang, Y., Zhao, J., Ruan, J., Luo, X., Lou, X., Bai, Y., et al. (2020) · Nature Immunology · doi:10.1038/s41590-020-0669-6 · Cited by 1,145 · see citing works

Interleukin-1 and Related Cytokines in the Regulation of Inflammation and Immunity

Mantovani, A., Dinarello, C. A., Molgora, M., & Garlanda, C. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.012 · Cited by 1,046 · see citing works

Double-Stranded RNA Is Produced by Positive-Strand RNA Viruses and DNA Viruses but Not in Detectable Amounts by Negative-Strand RNA Viruses

Weber, F., Wagner, V., Rasmussen, S. B., Hartmann, R., & Paludan, S. R. (2006) · Journal of Virology · doi:10.1128/jvi.80.10.5059-5064.2006 · Cited by 957 · see citing works

Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade

Pascual, V., Allantaz, F., Arce, E., Punaro, M., & Banchereau, J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050473 · Cited by 923 · see citing works

Type I and Type III Interferons – Induction, Signaling, Evasion, and Application to Combat COVID-19

Park, A., & Iwasaki, A. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.05.008 · Cited by 909 · see citing works

Innate immune recognition of bacterial ligands by NAIPs determines inflammasome specificity

Kofoed, E. M., & Vance, R. E. (2011) · Nature · doi:10.1038/nature10394 · Cited by 894 · see citing works

Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients

Rodrigues, T. S., de Sá, K. S. G., Ishimoto, A. Y., Becerra, A., Oliveira, S., Almeida, L., Gonçalves, A. V., Perucello, D. B., Andrade, W. A., Castro, R., et al. (2021) · Journal of Experimental Medicine · doi:10.1084/jem.20201707 · Cited by 839 · see citing works

Gasdermin pores permeabilize mitochondria to augment caspase-3 activation during apoptosis and inflammasome activation

Rogers, C., Erkes, D. A., Nardone, A., Aplin, A. E., Fernandes‐Alnemri, T., & Alnemri, E. S. (2019) · Nature Communications · doi:10.1038/s41467-019-09397-2 · Cited by 834 · see citing works

The COVID-19 Host Genetics Initiative, a global initiative to elucidate the role of host genetic factors in susceptibility and severity of the SARS-CoV-2 virus pandemic

Initiative, T. C.-1. H. G. (2020) · European Journal of Human Genetics · doi:10.1038/s41431-020-0636-6 · Cited by 746 · see citing works

CrossMap: a versatile tool for coordinate conversion between genome assemblies

Zhao, H., Sun, Z., Wang, J., Huang, H., Kocher, J., & Wang, L. (2013) · Bioinformatics · doi:10.1093/bioinformatics/btt730 · Cited by 718 · see citing works

An Infectious cDNA Clone of SARS-CoV-2

Xie, X., Muruato, A., Lokugamage, K. G., Narayanan, K., Zhang, X., Zou, J., Liu, J., Schindewolf, C., Bopp, N. E., Aguilar, P. V., et al. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.04.004 · Cited by 647 · see citing works

Succination inactivates gasdermin D and blocks pyroptosis

Humphries, F., Shmuel-Galia, L., Ketelut-Carneiro, N., Li, S., Wang, B.-W., Nemmara, V. V., Wilson, R., Jiang, Z., Khalighinejad, F., Muneeruddin, K., et al. (2020) · Science · doi:10.1126/science.abb9818 · Cited by 627 · see citing works

The role of IgG Fc receptors in antibody-dependent enhancement

Bournazos, S., Gupta, A., & Ravetch, J. V. (2020) · Nature reviews. Immunology · doi:10.1038/s41577-020-00410-0 · Cited by 625 · see citing works

Distribution of ACE2, CD147, CD26, and other SARS‐CoV‐2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID‐19 risk factors

Radzikowska, U., Ding, M., Tan, G., Zhakparov, D., Peng, Y., Wawrzyniak, P., Wang, M., Li, S., Morita, H., Altunbulakli, C., et al. (2020) · Allergy · doi:10.1111/all.14429 · Cited by 542 · see citing works

The potential danger of suboptimal antibody responses in COVID-19

Iwasaki, A., & Yang, Y.-X. (2020) · Nature reviews. Immunology · doi:10.1038/s41577-020-0321-6 · Cited by 510 · see citing works

A perspective on potential antibody-dependent enhancement of SARS-CoV-2

Arvin, A. M., Fink, K., Schmid, M. A., Cathcart, A., Spreafico, R., Havenar-Daughton, C., Lanzavecchia, A., Corti, D., & Virgin, H. W. (2020) · Nature · doi:10.1038/s41586-020-2538-8 · Cited by 485 · see citing works

Bias in causal estimates from Mendelian randomization studies with weak instruments

Burgess, S., & Thompson, S. G. (2011) · Statistics in Medicine · doi:10.1002/sim.4197 · Cited by 421 · see citing works

Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity

Larsen, M. D., de Graaf, E. L., Sonneveld, M. E., Plomp, H. R., Nouta, J., Hoepel, W., Chen, H.-J., Linty, F., Visser, R., Brinkhaus, M., et al. (2021) · Science · doi:10.1126/science.abc8378 · Cited by 408 · see citing works

Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China

Xu, X., Sun, J., Nie, S., Li, H., Kong, Y., Liang, M., Hou, J., Huang, X., Li, D., Ma, T., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0949-6 · Cited by 405 · see citing works

Structure and drug binding of the SARS-CoV-2 envelope protein transmembrane domain in lipid bilayers

Mandala, V. S., McKay, M. J., Shcherbakov, A. A., Dregni, A. J., Kolocouris, A., & Hong, M. (2020) · Nature Structural & Molecular Biology · doi:10.1038/s41594-020-00536-8 · Cited by 405 · see citing works

A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: lessons from other pathogenic viruses

Fung, S., Yuen, K., Ye, Z., Chan, C., & Jin, D. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1736644 · Cited by 383 · see citing works

The Pyrin Inflammasome in Health and Disease

Schnappauf, O., Chae, J. J., Kastner, D. L., & Aksentijevich, I. A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01745 · Cited by 365 · see citing works

Dampened NLRP3-mediated inflammation in bats and implications for a special viral reservoir host

Ahn, M., Anderson, D. E., Zhang, Q., Tan, C. W., Lim, B. L., Luko, K., Wen, M., Chia, W. N., Mani, S., Wang, L. C., et al. (2019) · Nature Microbiology · doi:10.1038/s41564-019-0371-3 · Cited by 334 · see citing works

Proinflammatory IgG Fc structures in patients with severe COVID-19

Chakraborty, S., Gonzalez, J., Edwards, K., Mallajosyula, V., Buzzanco, A. S., Sherwood, R., Buffone, C., Kathale, N., Providenza, S., Xie, M. M., et al. (2021) · Nature Immunology · doi:10.1038/s41590-020-00828-7 · Cited by 326 · see citing works

Cryo-EM structure of SARS-CoV-2 ORF3a in lipid nanodiscs

Kern, D. M., Sorum, B., Mali, S. S., Hoel, C., Sridharan, S., Remis, J. P., Toso, D. B., Kotecha, A., Bautista, D. M., & Brohawn, S. G. (2021) · Nature Structural & Molecular Biology · doi:10.1038/s41594-021-00619-0 · Cited by 316 · see citing works

Longitudinal proteomic analysis of severe COVID-19 reveals survival-associated signatures, tissue-specific cell death, and cell-cell interactions

Filbin, M. R., Mehta, A., Schneider, A. M., Kays, K. R., Guess, J. R., Gentili, M., Fenyves, B. G., Charland, N. C., Gonye, A. L. K., Gushterova, I., et al. (2021) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100287 · Cited by 296 · see citing works

Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19

Li, K., Huang, B., Wu, M., Zhong, A., Li, L., Cai, Y., Wang, Z., Wu, L., Zhu, M., Li, J., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19943-y · Cited by 259 · see citing works

Longitudinal immune profiling reveals key myeloid signatures associated with COVID-19

Mann, E. R., Menon, M., Knight, S., Konkel, J. E., Jagger, C. P., Shaw, T. N., Krishnan, S., Rattray, M., Ustianowski, A., Bakerly, N. D., et al. (2020) · Science Immunology · doi:10.1126/sciimmunol.abd6197 · Cited by 242 · see citing works

Aging immunity may exacerbate COVID-19

Akbar, A. N., & Gilroy, D. W. (2020) · Science · doi:10.1126/science.abb0762 · Cited by 209 · see citing works

Coronaviruses: Innate Immunity, Inflammasome Activation, Inflammatory Cell Death, and Cytokines

Lee, S., Channappanavar, R., & Kanneganti, T. (2020) · Trends in Immunology · doi:10.1016/j.it.2020.10.005 · Cited by 205 · see citing works

SARS-CoV-2 evolution in an immunocompromised host reveals shared neutralization escape mechanisms

Clark, S., Clark, L., Pan, J., Coscia, A., McKay, L. G. A., Shankar, S., Johnson, R. I., Brusic, V., Choudhary, M., Regan, J., et al. (2021) · Cell · doi:10.1016/j.cell.2021.03.027 · Cited by 176 · see citing works

Severe Acute Respiratory Syndrome Coronavirus 2–Induced Immune Activation and Death of Monocyte-Derived Human Macrophages and Dendritic Cells

Zheng, J. H., Wang, Y., Li, K., Meyerholz, D. K., Allamargot, C., & Perlman, S. M. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa753 · Cited by 155 · see citing works

A noncanonical function of cGAMP in inflammasome priming and activation

Swanson, K. V., Junkins, R. D., Kurkjian, C. J., Holley-Guthrie, E., Pendse, A. A., Morabiti, R. E., Petrucelli, A., Barber, G. N., Benedict, C. A., & Ting, J. P. ‐. (2017) · The Journal of Experimental Medicine · doi:10.1084/jem.20171749 · Cited by 148 · see citing works

The Human FcγRII (CD32) Family of Leukocyte FcR in Health and Disease

Anania, J. C., Chenoweth, A. M., Wines, B. D., & Hogarth, P. M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00464 · Cited by 146 · see citing works

AIM2 Inflammasome Is Critical for Influenza-Induced Lung Injury and Mortality

Zhang, H., Luo, J., Alcorn, J. F., Chen, K., Fan, S., Pilewski, J. M., Liu, A., Chen, W., Kolls, J. K., & Wang, J. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1600714 · Cited by 122 · see citing works

RNA viruses promote activation of the NLRP3 inflammasome through cytopathogenic effect-induced potassium efflux

da Costa, L. S., Outlioua, A., Anginot, A., Akarid, K., & Arnoult, D. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1579-0 · Cited by 118 · see citing works

Cryo-EM structure of the SARS-CoV-2 3a ion channel in lipid nanodiscsPreprint

Kern, D. M., Sorum, B., Mali, S. S., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.06.17.156554 · Cited by 113 · see citing works

Structural insight into the role of novel SARS-CoV-2 E protein: A potential target for vaccine development and other therapeutic strategies

Sarkar, M., & Saha, S. (2020) · PLoS ONE · doi:10.1371/journal.pone.0237300 · Cited by 106 · see citing works

Calpain drives pyroptotic vimentin cleavage, intermediate filament loss, and cell rupture that mediates immunostimulation

Davis, M. A., Fairgrieve, M. R., Den Hartigh, A., Yakovenko, O., Duvvuri, B., Lood, C., Thomas, W. E., Fink, S. L., & Gale, M. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1818598116 · Cited by 104 · see citing works

AIM2 Inflammasome-Mediated Pyroptosis in Enterovirus A71-Infected Neuronal Cells Restricts Viral Replication

Yogarajah, T., Ong, K. C., Perera, D., & Wong, K. T. (2017) · Scientific Reports · doi:10.1038/s41598-017-05589-2 · Cited by 84 · see citing works

Plasma proteomics reveals tissue-specific cell death and mediators of cell-cell interactions in severe COVID-19 patientsPreprint

Filbin, M. R., Mehta, A., Schneider, A. M., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.11.02.365536 · Cited by 49 · see citing works

Detection of viruses by inflammasomes

Spel, L., & Martinon, F. (2020) · Current Opinion in Virology · doi:10.1016/j.coviro.2020.10.001 · Cited by 38 · see citing works

Molecular basis for a germline-biased neutralizing antibody response to SARS-CoV-2Preprint

Clark, S. A., Clark, L. E., Pan, J., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.11.13.381533 · Cited by 27 · see citing works

High expression of angiotensin-converting enzyme-2 (ACE2) on tissue macrophages that may be targeted by virus SARS-CoV-2 in COVID-19 patientsPreprint

Song, X. H., Hu, W., Yu, H., Zhao, L., Zhao, Y., & Zhao, Y. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.07.18.210120 · Cited by 22 · see citing works

Innate immunity: the first line of defense against SARS-CoV-2

Diamond, M., & Kanneganti, T. (2022) · Nature Immunology · doi:10.1038/s41590-021-01091-0 · Cited by 612 · see citing works

SARS-CoV-2, COVID-19 and the aging immune system

Bartleson, J. M., Radenkovic, D., Covarrubias, A. J., Furman, D., Winer, D. A., & Verdin, E. (2021) · Nature Aging · doi:10.1038/s43587-021-00114-7 · Cited by 359 · see citing works

Inflammasome activation at the crux of severe COVID-19

Vora, S. M., Lieberman, J., & Wu, H. (2021) · Nature reviews. Immunology · doi:10.1038/s41577-021-00588-x · Cited by 323 · see citing works

Innate immunological pathways in COVID-19 pathogenesis

Paludan, S. R., & Mogensen, T. H. (2022) · Science Immunology · doi:10.1126/sciimmunol.abm5505 · Cited by 186 · see citing works

Human NLRP1 is a sensor of pathogenic coronavirus 3CL proteases in lung epithelial cells

Planès, R., Pinilla, M., Santoni, K., Hessel, A., Passemar, C., Lay, K., Paillette, P., Valadão, A. L. C., Robinson, K. S., Bastard, P., et al. (2022) · Molecular Cell · doi:10.1016/j.molcel.2022.04.033 · Cited by 150 · see citing works

Immune response in COVID-19: what is next?

Li, Q., Wang, Y., Sun, Q., Knopf, J., i, M. H., Lin, L., Jiang, J., Shao, C., Li, P., He, X., et al. (2022) · Cell Death and Differentiation · doi:10.1038/s41418-022-01015-x · Cited by 140 · see citing works

Specific inhibition of the NLRP3 inflammasome suppresses immune overactivation and alleviates COVID-19 like pathology in mice

Zeng, J., Xie, X., Feng, X., Xu, L., Han, J.-B., Yu, D., Zou, Q., Liu, Q., Li, X., Ma, G., et al. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103803 · Cited by 128 · see citing works

PANoptosis in Viral Infection: The Missing Puzzle Piece in the Cell Death Field

Nguyen, L. N., & Kanneganti, T. (2021) · Journal of Molecular Biology · doi:10.1016/j.jmb.2021.167249 · Cited by 98 · see citing works

Persistent Oxidative Stress and Inflammasome Activation in CD14highCD16− Monocytes From COVID-19 Patients

Lage, S. L., Amaral, E. P., Hilligan, K. L., Laidlaw, E., Rupert, A. W., Namasivayan, S., Rocco, J. M., Galindo, F., Kellogg, A., Kumar, P. N., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.799558 · Cited by 95 · see citing works

Ferroptosis, pyroptosis and necroptosis in acute respiratory distress syndrome

Zheng, Y., Huang, Y., Xu, Y., Sang, L., Liu, X., & Li, Y. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01369-2 · Cited by 76 · see citing works

Recent advances in ZBP1-derived PANoptosis against viral infections

Oh, S., & Lee, S. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1148727 · Cited by 75 · see citing works

The role of IL-1 family of cytokines and receptors in pathogenesis of COVID-19

Makaremi, S., Asgarzadeh, A., Kianfar, H., Mohammadnia, A., Asghariazar, V., & Safarzadeh, E. (2022) · Inflammation Research · doi:10.1007/s00011-022-01596-w · Cited by 68 · see citing works

Cell deaths: Involvement in the pathogenesis and intervention therapy of COVID-19

Li, X., Zhang, Z., Wang, Z., Gutiérrez-Castrellón, P., & Shi, H. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01043-6 · Cited by 67 · see citing works

Rhinovirus-induced epithelial RIG-I inflammasome suppresses antiviral immunity and promotes inflammation in asthma and COVID-19

Radzikowska, U., Eljaszewicz, A., Tan, G., Stocker, N., Heider, A., Westermann, P., Steiner, S., Dreher, A., Wawrzyniak, P., Rückert, B., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-37470-4 · Cited by 67 · see citing works

CD169-mediated restrictive SARS-CoV-2 infection of macrophages induces pro-inflammatory responses

Jalloh, S., Olejnik, J., Berrigan, J. L., Nisa, A., Suder, E. L., Akiyama, H., Lei, M., Ramaswamy, S., Tyagi, S., Bushkin, Y., et al. (2022) · PLoS Pathogens · doi:10.1371/journal.ppat.1010479 · Cited by 64 · see citing works

Caspase-4/11 exacerbates disease severity in SARS–CoV-2 infection by promoting inflammation and immunothrombosis

Eltobgy, M. M., Zani, A., Kenney, A. D., Estfanous, S. Z. K., Kim, E., Badr, A., Carafice, C., Daily, K. P., Whitham, O. D., Pietrzak, M., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2202012119 · Cited by 61 · see citing works

Diabetes and coronavirus (SARS-CoV-2): Molecular mechanism of Metformin intervention and the scientific basis of drug repurposing

Varghese, E., Samuel, S. M., Líšková, A., Kubatka, P., & Büsselberg, D. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009634 · Cited by 64 · see citing works

Bat ASC2 suppresses inflammasomes and ameliorates inflammatory diseases

Ahn, M., Chen, V. C.-W., Rozario, P., Ng, W. L., Kong, P. S., Sia, W. R., Kang, A. E. Z., Su, Q., Nguyen, L. H., Zhu, F., et al. (2023) · Cell · doi:10.1016/j.cell.2023.03.036 · Cited by 62 · see citing works

Colchicine for COVID-19: targeting NLRP3 inflammasome to blunt hyperinflammation

Bonaventura, A., Vecchié, A., Dagna, L., Tangianu, F., Abbate, A., & Dentali, F. (2022) · Inflammation Research · doi:10.1007/s00011-022-01540-y · Cited by 64 · see citing works

Programmed cell death: the pathways to severe COVID-19?

Bader, S. M., Cooney, J. P., Pellegrini, M., & Doerflinger, M. (2022) · Biochemical Journal · doi:10.1042/bcj20210602 · Cited by 54 · see citing works

In COVID-19, NLRP3 inflammasome genetic variants are associated with critical disease and these effects are partly mediated by the sickness symptom complex: a nomothetic network approach

Maes, M. H. J., Tedesco, W. L. D., Lozovoy, M. A. B., Mori, M. T. E., Danelli, T., de Almeida, E. R. D., Tejo, A. M., Tano, Z. N., Reiche, E. M. V., & Simão, A. N. C. (2022) · Molecular Psychiatry · doi:10.1038/s41380-021-01431-4 · Cited by 53 · see citing works

NLRP3 inflammasome activation in COVID-19: an interlink between risk factors and disease severity

Amin, S., Aktar, S., Rahman, M. M., & Chowdhury, M. M. H. (2022) · Microbes and Infection · doi:10.1016/j.micinf.2021.104913 · Cited by 51 · see citing works

Toll-Like Receptors (TLRs) in Health and Disease: An Overview.

Kumar, V., & Barrett, J. E. (2022) · Handbook of Experimental Pharmacology · doi:10.1007/164_2021_568 · Cited by 40 · see citing works

SARS-CoV-2 infection and liver involvement

Luo, M., Ballester, M., Soffientini, U., Jalan, R., & Mehta, G. (2022) · Hepatology International · doi:10.1007/s12072-022-10364-1 · Cited by 39 · see citing works

The BNT162b2 mRNA SARS-CoV-2 vaccine induces transient afucosylated IgG1 in naive but not in antigen-experienced vaccinees

Coillie, J. V., Pongrácz, T., Rahmöller, J., Chen, H., Geyer, C. E., van Vught, L. A., Buhre, J. S., Šuštić, T., van Osch, T. L. J., Steenhuis, M., et al. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.104408 · Cited by 46 · see citing works

Potential benefits of ginseng against COVID-19 by targeting inflammasomes

Yi, Y. (2022) · Journal of Ginseng Research · doi:10.1016/j.jgr.2022.03.008 · Cited by 43 · see citing works

Generation and Functional Analysis of Defective Viral Genomes during SARS-CoV-2 Infection

Zhou, T., Gilliam, N. J., Li, S., Spandau, S., Osborn, R. M., Connor, S., Anderson, C., Mariani, T. J., Thakar, J., Dewhurst, S., et al. (2023) · mBio · doi:10.1128/mbio.00250-23 · Cited by 41 · see citing works

Pyroptotic cell death in SARS-CoV-2 infection: revealing its roles during the immunopathogenesis of COVID-19

Wang, M., Chang, W., Zhang, L., & Zhang, Y. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.77561 · Cited by 34 · see citing works

Immunothrombosis and its underlying biological mechanisms

Nardi, A. C. D., Coy‐Canguçu, A., Saito, A., Florio, M. F., Marti, G. C. D. C. F., Degasperi, G. R., & Orsi, F. A. (2023) · Hematology Transfusion and Cell Therapy · doi:10.1016/j.htct.2023.05.008 · Cited by 36 · see citing works

Cytosolic nucleic acid sensing as driver of critical illness: mechanisms and advances in therapy

Chen, Z., Behrendt, R., Wild, L., Schlee, M., & Bode, C. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02174-2 · Cited by 38 · see citing works

New insights into nucleic acid sensor AIM2: The potential benefit in targeted therapy for cancer

Cui, J.-Z., Chew, Z. H., & Lim, L. H. K. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107079 · Cited by 36 · see citing works

Role of the renin-angiotensin system in the development of COVID-19-associated neurological manifestations

Méndez-García, L. A., Escobedo, G., Minguer-Uribe, A. G., Viurcos-Sanabria, R., Aguayo-Guerrero, J. A., Carrillo-Ruiz, J. D., & Solleiro-Villavicencio, H. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.977039 · Cited by 33 · see citing works

The Good and Bad of Nrf2: An Update in Cancer and New Perspectives in COVID-19

Emanuele, S., Celesia, A., D’Anneo, A., Lauricella, M., Carlisi, D., BLASIO, A. D., & Giuliano, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22157963 · Cited by 30 · see citing works

Innate and adaptive immunity to SARS-CoV-2 and predisposing factors

Shen, J., Fan, J., Zhao, Y., Jiang, D., Niu, Z., Zhang, Z., & Cao, G. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1159326 · Cited by 31 · see citing works

Korean Red Ginseng, a regulator of NLRP3 inflammasome, in the COVID-19 pandemic

Jung, E., & Lee, G. (2022) · Journal of Ginseng Research · doi:10.1016/j.jgr.2022.02.003 · Cited by 28 · see citing works

Baricitinib attenuates the proinflammatory phase of COVID-19 driven by lung-infiltrating monocytes

Dobosh, B., Zandi, K., Giraldo, D. M., Goh, S. L., Musall, K., Aldeco, M., LeCher, J., Giacalone, V. D., Yang, J., Eddins, D. J., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110945 · Cited by 19 · see citing works

Severe COVID ‐19 patients show a dysregulation of the NLRP3 inflammasome in circulating neutrophils

Leal, V. N. C., Andrade, M. M. S., Teixeira, F. M. E., Cambui, R. A. G., Roa, M. E. G. V., Marra, L. G., Yamada, S. M., Alberca, R. W., Gozzi-Silva, S. C., Yendo, T. M., et al. (2022) · Scandinavian Journal of Immunology · doi:10.1111/sji.13247 · Cited by 17 · see citing works

Pyroptosis-triggered pathogenesis: New insights on antiphospholipid syndrome

Tan, Y., Liu, Q., Li, Z., Yang, S., & Cui, L. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1155222 · Cited by 16 · see citing works

Drug delivery systems as immunomodulators for therapy of infectious disease: Relevance to COVID-19

Brain, D. E., Plant-Hately, A. J., Heaton, B. J., Arshad, U., David, C. A. W., Hedrich, C. M., Owen, A., & Liptrott, N. J. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113848 · Cited by 13 · see citing works

Network modeling-based identification of the switching targets between pyroptosis and secondary pyroptosis

Zhu, L., Li, X., Xu, F., Yin, Z., Jin, J., Liu, Z., Qi, H., & Shuai, J. (2022) · Chaos Solitons & Fractals · doi:10.1016/j.chaos.2021.111724 · Cited by 13 · see citing works

Presepsin value predicts the risk of developing severe/critical COVID-19 illness: results of a pooled analysis

Lippi, G., Sanchis‐Gomar, F., & Henry, B. M. (2021) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2021-0848 · Cited by 12 · see citing works

Cellular heterogeneity in disease severity and clinical outcome: Granular understanding of immune response is key

Khare, K., & Pandey, R. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.973070 · Cited by 11 · see citing works

Severe Clinical Worsening in COVID-19 and Potential Mechanisms of Immune-Enhanced Disease

Hussman, J. P. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.637642 · Cited by 11 · see citing works

Proteomic analysis and identification reveal the anti-inflammatory mechanism of clofazimine on lipopolysaccharide-induced acute lung injury in mice

Yang, B., Gao, Z. J., Li, Q.-S., Zhang, X.-Y., Song, L., Wang, Y., Wang, X., Ji, L., Xu, H., Xie, H., et al. (2022) · Inflammation Research · doi:10.1007/s00011-022-01623-w · Cited by 11 · see citing works

Ox-inflammasome involvement in neuroinflammation

Vallese, A., Cordone, V., Pecorelli, A., & Valacchi, G. (2023) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2023.07.010 · Cited by 10 · see citing works

Through DNA sensors and hidden mitochondrial effects of SARS-CoV-2

Targhetta, V. P., do Amaral, M. A., & Câmara, N. O. S. (2021) · The Journal of venomous animals and toxins including tropical diseases · doi:10.1590/1678-9199-jvatitd-2020-0183 · Cited by 10 · see citing works

Caspase-1 activation, IL-1/IL-6 signature and IFNγ-induced chemokines in lungs of COVID-19 patients

Cambon, A., Guervilly, C., Delteil, C., Potere, N., Bachelier, R., Tellier, E., Abdili, E., Leprince, M., Giani, M., Polidoro, I., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1493306 · Cited by 9 · see citing works

IL-1β drives SARS-CoV-2-induced disease independently of the inflammasome and pyroptosis signalling

Bader, S. M., Scherer, L., Schaefer, J., Cooney, J. P., Mackiewicz, L., Dayton, M., Georgy, S. R., Davidson, K. C., Allison, C. C., Herold, M. J., et al. (2025) · Cell Death and Differentiation · doi:10.1038/s41418-025-01459-x · Cited by 13 · see citing works

Coordinated regulation of interferon and inflammasome signaling pathways by SARS-CoV-2 proteins

Kim, N., & Song, Y. (2022) · The Journal of Microbiology · doi:10.1007/s12275-022-1502-8 · Cited by 9 · see citing works

NLRP3-dependent pyroptosis exacerbates coxsackievirus A16 and coxsackievirus A10-induced inflammatory response and viral replication in SH-SY5Y cells

Hu, Y., Zhao, W., Lv, Y., Li, H., Jiang, L., Zhong, M., Pu, D., Jian, F., Song, J., & Zhang, Y. (2024) · Virus Research · doi:10.1016/j.virusres.2024.199386 · Cited by 8 · see citing works

Inflammasome-related Markers upon ICU Admission do not Correlate with Outcome in Critically Ill COVID-19 Patients

Adamik, B., Ambrożek-Latecka, M., Dragan, B., Jeznach, A., Śmiechowicz, J., Goździk, W., & Skirecki, T. (2022) · Shock · doi:10.1097/shk.0000000000001923 · Cited by 8 · see citing works

Diverse strategies utilized by coronaviruses to evade antiviral responses and suppress pyroptosis

Fu, X., Xu, W., Yang, Y., Li, D., Shi, W., Li, X., Chen, N., Lv, Q., Shi, Y., Xu, J., et al. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.139743 · Cited by 8 · see citing works

SARS-CoV-2 drives NLRP3 inflammasome activation in human microglia through spike-ACE2 receptor interactionPreprint

Albornoz, E. A., Amarilla, A. A., Modhiran, N., Parker, S. E., Li, X. X., Wijesundara, D. K., Zamora, A. C. P., McMillan, C. L. D., Liang, B., Peng, N. Y. G., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.01.11.475947 · Cited by 8 · see citing works

Variation in presepsin and thrombomodulin levels for predicting COVID-19 mortality

Yamazaki, A., Nukui, Y., Kameda, T., Saito, R., Koda, Y., Ichimura, N., Tohda, S., & Ohkawa, R. (2023) · Scientific Reports · doi:10.1038/s41598-023-48633-0 · Cited by 6 · see citing works

Self-DNA driven inflammation in COVID-19 and after mRNA-based vaccination: lessons for non-COVID-19 pathologies

Heil, M. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1259879 · Cited by 6 · see citing works

Monoclonal Human Antibodies That Recognise the Exposed N and C Terminal Regions of the Often-Overlooked SARS-CoV-2 ORF3a Transmembrane Protein

Tan, T. H., Patton, E., Munro, C. A., Corzo-León, D., Porter, A. J., & Palliyil, S. (2021) · Viruses · doi:10.3390/v13112201 · Cited by 5 · see citing works

Macrophages only sense infectious SARS-CoV-2 when they express sufficient ACE2 to permit viral entry, where rapid cytokine responses then limit viral replicationPreprint

Labzin, L. I., Chew, K. Y., Eschke, K., Wang, X., Esposito, T., Stocks, C. J., Rae, J. A., Patrick, R., Mostafavi, H., Hill, B., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.03.22.485248 · Cited by 3 · see citing works

Precision medicine and machine learning to predict critical disease and death due to Coronavirus disease 2019 (COVID-19)

Tedesco, W. L. D., Danelli, T., Tano, Z. N., Cassela, P. L. C. S., Trigo, G. L., Cardoso, K. D. M., Loni, L. P., Ahrens, T. M., Espinosa, B. R., Fernandes, Á. J., et al. (2025) · Human Immunology · doi:10.1016/j.humimm.2025.111337 · Cited by 2 · see citing works

Investigation of the effect of serum gasdermin d levels on clinical course and mortality in patients with covid-19

Türker, M., ÖNDER, K. D., & Çekın, Y. (2025) · BMC Infectious Diseases · doi:10.1186/s12879-025-11277-8 · Cited by 2 · see citing works

Protective effects of IL18-105G > A and IL18-137C > G genetic variants on severity of COVID-19

Mori, M. T. E., Simão, A. N. C., Danelli, T., Oliveira, S. R., Cassela, P. L. C. S., Trigo, G. L., Cardoso, K. M., Tejo, A. M., Tano, Z. N., de Almeida, E. R. D., et al. (2023) · Cytokine · doi:10.1016/j.cyto.2023.156476 · Cited by 2 · see citing works

Models for SARS-CoV-2 associated thrombocytopenia associated with hemophagocytic histiocytes

Ricke, D. O. (2021) · Medical Hypotheses · doi:10.1016/j.mehy.2021.110700 · Cited by 2 · see citing works

Potential role of AIM2 inflammasome in SARS‐CoV ‐2 infection

Uresti‐Rivera, E. E., & García-Hernández, M. H. (2022) · Scandinavian Journal of Immunology · doi:10.1111/sji.13239 · Cited by 2 · see citing works

Innate immunity, therapeutic targets and monoclonal antibodies in SARS-CoV-2 infection

Nazir, M., Mir, I. R., Lone, S. A., Muteeb, G., Alam, R., Fomda, A. B., Khan, N., Azhar, A., Fomda, B. A., & Khan, W. H. (2025) · PeerJ · doi:10.7717/peerj.19462 · Cited by 1 · see citing works

Innate and SARS-CoV-2 specific adaptive immune response kinetic in neutralizing monoclonal antibody successfully treated COVID-19 patients

Casetti, R., Sacchi, A., Mazzotta, V., Cristofanelli, F., Grassi, G., Gili, S., Cimini, E., Notari, S., Bordoni, V., Mastrorosa, I., et al. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113934 · Cited by 1 · see citing works

Human NLRP1 Is a Sensor of 3CL Proteases from Pathogenic Coronaviruses in Lung Epithelial CellsPreprint

Planès, R., Pinilla, M., Santoni, K., Hessel, A., Lay, K., Paillette, P., Valadão, A. L. C., Robinson, K. S., Bastard, P., Rossi, I., et al. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3948202 · Cited by 1 · see citing works

Implications of SARS‐CoV‐2 Immunity in the Context of the Pathogenesis of COVID‐19, Immune Evasion of the Virus, and the Effectiveness of VaccinationPreprint

Akkız, H. (2024) · Preprints.org · doi:10.20944/preprints202405.1826.v1

Immature Myeloid Cell Deposition in Old Bone Marrow Revealed by Single-Cell Transcriptome AnalysisPreprint

Kim, W.-J., Kim, K., Moon, J.-I., Park, S. G., Cho, Y., Kim, H. J., Shin, H., Yoon, H., & Ryoo, H. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.10.15.512392

From Mild Cases to Critical Cases of COVID-19: The Role of Genes in Inflammasome and Mitochondrial Dynamics

Kia, A., Hajhasan, V., Nadi, M., Jamalkandi, S. A., Parvin, S., Saffaei, A., Basirjafar, P., Salimian, J., & Samei, A. (2024) · Iranian Journal of Allergy Asthma and Immunology · doi:10.18502/ijaai.v23i4.16213

Study of the pharmacological activity of a supplement based on ginsenoside of 6-year-old ginseng root against the infectious bronchitis virus of chickens

Ledeneva, O. Y., Ryasnyansky, M. A., Drobot, E. V., Герунова, Л. К., Владимирович, Г. Т., Hyuk, K. H., Ermakova, L. P., & Kilp, A. S. (2026) · Bulletin of NSAU (Novosibirsk State Agrarian University) · doi:10.31677/2072-6724-2025-77-4-204-216

NLRP3 inflammasome activation in astrocytes restricts SARS-CoV-2 through gasdermin-D-driven IL-1β release

de Farias, I. S., Duarte-Barbosa, M., Salazar, N., Andreata‐Santos, R., Lucena, V. W. L., Maricato, J. T., Gazzinelli, R. T., Janini, L. M., & Bortoluci, K. R. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1703765

FcγR-mediated SARS-CoV-2 infection of monocytes activates inflammation

Junqueira, C., Crespo, Â. C., Ranjbar, S., de Lacerda, L., Lewandrowski, M., Ingber, J., Parry, B. A., Ravid, S., Clark, S. A., Schrimpf, M. R., et al. (2022) · Nature · doi:10.1038/s41586-022-04702-4 · Cited by 669 · see citing works

SARS-CoV-2 infection of monocytes: balancing acts of antibodies and inflammasomes

Brewer, R. C., Robinson, W. H., & Lanz, T. V. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01112-w · Cited by 7 · see citing works

Opsonizing antibodies mediated SARS‐CoV‐2 entry into monocytes leads to inflammation

Yao, T., Wang, S., Zhang, L., Lau, J. Y., & Zhou, F. (2022) · MedComm – Future Medicine · doi:10.1002/mef2.11 · Cited by 1 · see citing works

SARS-CoV-2 engages inflammasome and pyroptosis in human primary monocytes

Ferreira, A. C., Soares, V. C., de Azevedo-Quintanilha, I. G., Dias, S. D. S. G., Rodrigues, N. F., Sacramento, C. Q., Mattos, M., de Freitas, C. S., Temerozo, J. R., Teixeira, L., et al. (2021) · Cell Death Discovery · doi:10.1038/s41420-021-00428-w · Cited by 269 · see citing works

Monocytes as targets

Visan, I. (2022) · Nature Immunology · doi:10.1038/s41590-022-01205-2 · Cited by 2 · see citing works